Comparison of measurement between Xe/CT CBF and PET in cerebrovascular disease and brain tumor.
Nariai
T
T
Department of Neurosurgery, Tokyo Medical & Dental University, Japan.
D000086:Acetazolamide; D000328:Adult; D000368:Aged; D016477:Artifacts; D001783:Blood Flow Velocity / Q000187:drug effects / Q000502:physiology; D001921:Brain / Q000098:blood supply*; D001932:Brain Neoplasms / Q000000981:diagnostic imaging* / Q000503:physiopathology / Q000601:surgery; D002561:Cerebrovascular Disorders / Q000000981:diagnostic imaging* / Q000503:physiopathology / Q000601:surgery; D003287:Contrast Media; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012039:Regional Blood Flow / Q000187:drug effects / Q000502:physiology; D014055:Tomography, Emission-Computed; D014057:Tomography, X-Ray Computed; D014980:Xenon Radioisotopes
D003287:Contrast Media; D014980:Xenon Radioisotopes; D000086:Acetazolamide